loadpatents
name:-0.025082111358643
name:-0.013407945632935
name:-0.0025689601898193
AVEN; Michael Patent Filings

AVEN; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for AVEN; Michael.The latest application filed is for "preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition".

Company Profile
10.21.34
  • AVEN; Michael - Mainz DE
  • Aven; Michael - Ingelheim am Rhein DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Preserved Etherified Cyclodextrin Derivatives Containing Liquid Aqueous Pharmaceutical Composition
App 20220040313 - AVEN; Michael ;   et al.
2022-02-10
Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
Grant 11,185,590 - Aven , et al. November 30, 2
2021-11-30
Pharmaceutical Formulation Comprising Ciclesonide
App 20210106685 - AVEN; Michael ;   et al.
2021-04-15
Pharmaceutical formulation comprising ciclesonide
Grant 10,925,964 - Aven , et al. February 23, 2
2021-02-23
Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
Grant 10,682,345 - Albrecht , et al.
2020-06-16
Container for an inhaler
Grant 10,603,451 - Reinecke , et al.
2020-03-31
Ciclesonide for the treatment of airway disease in horses
Grant 10,441,597 - Albrecht , et al. Oc
2019-10-15
Muscarinic Antagonists And Combinations Thereof For The Treatment Of Airway Disease In Horses
App 20190262329 - ALBRECHT; Balazs ;   et al.
2019-08-29
Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
Grant 10,342,789 - Albrecht , et al. July 9, 2
2019-07-09
Ciclesonide for the treatment of airway disease in horses
Grant 10,258,634 - Albrecht , et al.
2019-04-16
Inhaler
App 20180361088 - Knell; Marcus ;   et al.
2018-12-20
Preserved Etherified Cyclodextrin Derivatives Containing Liquid Aqueous Pharmaceutical Composition
App 20180339054 - AVEN; Michael ;   et al.
2018-11-29
Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
Grant 10,071,162 - Aven , et al. September 11, 2
2018-09-11
Inhaler
Grant 10,046,124 - Knell , et al. August 14, 2
2018-08-14
Ciclesonide for the Treatment of Airway Disease in Horses
App 20180153907 - ALBRECHT; Balazs ;   et al.
2018-06-07
Ciclesonide for the treatment of airway disease in horses
Grant 9,918,995 - Albrecht , et al. March 20, 2
2018-03-20
Container For An Inhaler
App 20170368274 - REINECKE; Holger ;   et al.
2017-12-28
Ciclesonide For The Treatment Of Airway Disease In Horses
App 20170079988 - ALBRECHT; Balazs ;   et al.
2017-03-23
Muscarinic Antagonists And Combinations Thereof For The Treatment Of Airway Disease In Horses
App 20170007593 - ALBRECHT; Balazs ;   et al.
2017-01-12
Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
Grant 9,474,747 - Albrecht , et al. October 25, 2
2016-10-25
Muscarinic Antagonists And Combinations Thereof For The Treatment Of Airway Disease In Horses
App 20150366855 - ALBRECHT; Balazs ;   et al.
2015-12-24
Ciclesonide For The Treatment Of Airway Disease In Horses
App 20150313918 - ALBRECHT; Balazs ;   et al.
2015-11-05
Inhaler
App 20150053202 - Knell; Marcus ;   et al.
2015-02-26
Preserved Etherified Cyclodextrin Derivatives Containing Liquid Aqueous Pharmaceutical Composition
App 20150025082 - AVEN; Michael ;   et al.
2015-01-22
Pharmaceutical Formulation Comprising Ciclesonide
App 20140179650 - AVEN; Michael ;   et al.
2014-06-26
Ciclesonide For The Treatment Of Airway Disease In Horses
App 20140179651 - ALBRECHT; Balazs ;   et al.
2014-06-26
Aerosol Formulation For The Inhalation Of Beta Agonists
App 20120058980 - RADAU; Kirsten ;   et al.
2012-03-08
Aerosol Formulation For The Inhalation Of Beta-agonists
App 20120035169 - AVEN; Michael
2012-02-09
Aerosol Formulation For The Inhalation Of Beta Agonists
App 20110281858 - Aven; Michael
2011-11-17
Crystalline Hydrate Of Betamimetika And Use As Medicament Thereof
App 20100331288 - Aven; Michael ;   et al.
2010-12-30
Aerosol formulation for the inhalation of beta-agonists
App 20080293710 - Aven; Michael
2008-11-27
Aerosol Formulation for Inhalation
App 20080280897 - Aven; Michael
2008-11-13
Aerosol Formulation For The Inhalation Of Beta Agonists
App 20080053430 - Nowak; Michael ;   et al.
2008-03-06
Aerosol Formulation For The Inhalation Of Beta Agonists
App 20080041369 - RADAU; Kirsten ;   et al.
2008-02-21
Aerosol Formulation For The Inhalation Of Beta Agonists
App 20080041370 - RADAU; Kirsten ;   et al.
2008-02-21
Fungicidal formulation
Grant 7,176,209 - Aven , et al. February 13, 2
2007-02-13
Aerosol formulation for the inhalation of beta-agonists
App 20050256115 - Aven, Michael
2005-11-17
Enhancement of the activity of carotenoid biosynthesis inhibitor herbicides
Grant 6,894,003 - Aven , et al. May 17, 2
2005-05-17
Non-aqueous emulsifiable concentrate formulation
Grant 6,872,736 - Aven March 29, 2
2005-03-29
Fungicidal formulation
App 20030176427 - Aven, Michael ;   et al.
2003-09-18
Enhancement of the efficacy of benzoylbenzenes
Grant 6,613,806 - Aven , et al. September 2, 2
2003-09-02
Enhancement of the efficacy of benzoylbenzenes
Grant 6,596,775 - Aven , et al. July 22, 2
2003-07-22
Emulsifiable concentrate containing one or more pesticides and adjuvants
Grant 6,566,308 - Aven May 20, 2
2003-05-20
Aqueous suspension concentrate
App 20030060514 - Aven, Michael
2003-03-27
Aqueous suspension concentrate
App 20020155954 - Aven, Michael
2002-10-24
Enhancement of the efficacy of triazolopyrimidines
App 20020045631 - Aven, Michael ;   et al.
2002-04-18
Enhancement of the activity of carotenoid biosynthesis inhibitor herbicides
App 20020039968 - Aven, Michael ;   et al.
2002-04-04
Enhancement of the efficacy of benzoylbenzenes
App 20020028778 - Aven, Michael ;   et al.
2002-03-07
Non-aqueous suspension concentrate
Grant 6,165,940 - Aven December 26, 2
2000-12-26
Enhancement of the efficacy of triazolopyrimidines
Grant 6,124,301 - Aven , et al. September 26, 2
2000-09-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed